Campbell & Company Strategies Inc.

  • Home
  • About Us
  • Our Services
    • Media and Public Relations
    • Writing and Editorial Services
    • Product Launches
    • Corporate Communications
    • Issues Management and Crisis Communications
    • Advertising, Print Production, Design and Typesetting
    • Presentation Skills and Media Interview Training
    • Trade Shows and Conferences
    • Strategic Research and Planning
    • Financial and Investor Communications
    • Event Management and Media Promotion
    • Market Research, Customer Surveys and Focus Groups
  • Our Clients
  • What Our Clients Say
  • Links

Mitochondrial medicine targets traumatic brain injury

June 10, 2013 by Steve

I wrote this article for the International Brain Injury Association’s NeuroTrauma Letter for my client NeuroVive Pharma. It’s entitled “TBI pharmaceuticals – the long odyssey of cyclosporine is almost over.”   IBIA NeuroTrauma Letter CsA article 1Q 2013 It’s also here http://www.internationalbrain.org/tbi-pharmaceuticals-the-long-odyssey-of-cyclosporine/

Filed Under: Uncategorized

Search this site

Contact Us

Campbell & Company Strategies Inc.
Vancouver, B.C. Canada
Tel: (604) 888-5267
Click to email us

Recent Articles

  • Kerry 2024 Taste Charts Global Media Coverage →

  • Renaissance immune support technology profiled in Feed Navigator international newsletter →

  • Kerry citrus flavors featured in FoodBev magazine →

  • Sonar manufacturer Kongsberg Mesotech →

  • Mazza Innovation’s pressurized water extraction process →

  • New brain scan a leap forward for CTE research →

© Copyright 2025 Campbell & Company Strategies Inc. · Vancouver, B.C. Canada · Tel: (604) 888-5267 · Email us